Suppr超能文献

甲状旁腺功能亢进患者在使用拟钙剂后发生肾移植失败。

Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic.

机构信息

Division of Nephrology and Immunology, RWTH University of Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.

出版信息

Nat Rev Nephrol. 2011 Apr;7(4):237-41. doi: 10.1038/nrneph.2010.169. Epub 2010 Dec 14.

Abstract

BACKGROUND

A 47-year-old man with a 6-year history of chronic dialysis for end-stage renal disease of unknown etiology presented for renal transplantation. While on dialysis, he had developed secondary hyperparathyroidism, which persisted after transplantation despite treatment with cinacalcet.

INVESTIGATIONS

Physical examination, serum and urine analysis, ultrasound of the renal transplant, renal biopsy, bone scintigraphy.

DIAGNOSIS

Severe persistent hyperparathyroidism associated with mild hypercalcemia following renal transplantation. Initiation of a calcimimetic followed by fulminant graft failure. Extensive tubular calcinosis.

MANAGEMENT

Renal transplantation (with immunosuppressant medications: basiliximab, tacrolimus, mycophenolate mofetil, prednisolone), cinacalcet (halted on day 26 after transplantation), angiotensinconverting-enzyme inhibitor, angiotensin-receptor blocker, hydrochlorothiazide, emergency dialysis, subtotal parathyroidectomy.

摘要

背景

一名 47 岁男性,因病因不明的终末期肾病接受慢性透析治疗已有 6 年,现因肾衰竭接受肾移植。在透析期间,他出现了继发性甲状旁腺功能亢进,尽管使用西那卡塞治疗,但在移植后仍持续存在。

检查

体格检查、血清和尿液分析、肾移植超声、肾活检、骨闪烁扫描。

诊断

肾移植后严重持续甲状旁腺功能亢进伴轻度高钙血症。钙敏感受体激动剂治疗后,迅速发生移植物衰竭。广泛的肾小管钙化。

治疗

肾移植(免疫抑制剂药物:巴利昔单抗、他克莫司、霉酚酸酯、泼尼松龙),西那卡塞(移植后第 26 天停用),血管紧张素转换酶抑制剂,血管紧张素受体阻滞剂,氢氯噻嗪,紧急透析,甲状旁腺次全切除术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验